CONMED Corporation
67.48
-0.31 (-0.46%)
At close: Jan 15, 2025, 9:38 AM

CONMED Corporation Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
General Surgery Revenue 186.16M 192.56M 190.52M 179.91M 176.86M 164.29M 135.66M 156.47M 157.01M 134.81M 156.36M 143.08M 147.27M 125.51M 135.65M 97.30M 114.73M 123.26M 122.51M 104.94M 99.38M 102.69M 93.20M 101.54M 91.54M 91.59M 82.78M 92.51M 85.44M 87.57M 75.90M 70.89M 66.12M 71.11M 66.06M 75.42M 69.73M 70.75M 63.46M 76.83M 69.89M 73.18M 66.85M
General Surgery Revenue Growth -3.32% +1.07% +5.90% +1.72% +7.65% +21.11% -13.30% -0.34% +16.47% -13.78% +9.28% -2.85% +17.33% -7.47% +39.41% -15.19% -6.92% +0.62% +16.74% +5.60% -3.22% +10.18% -8.21% +10.93% -0.06% +10.65% -10.52% +8.27% -2.43% +15.37% +7.06% +7.22% -7.01% +7.64% -12.40% +8.15% -1.43% +11.48% -17.40% +9.93% -4.51% +9.48% n/a
Orthopedic Surgery Revenue 130.54M 139.54M 136.53M 124.67M 140.79M 131.18M 115.21M 118.62M 120.18M 107.52M 117.61M 105.75M 107.89M 107.17M 102.19M 60.48M 99.28M 110.33M 115.76M 113.44M 102.93M 110.13M 108.86M 121.01M 98.58M 105.56M 103.79M 98.03M 86.26M 92.74M 93.44M 104.17M 89.38M 96.80M 98.60M 101.69M 92.75M 102.36M 105.95M 107.75M 95.56M 101.85M 105.01M
Orthopedic Surgery Revenue Growth -6.45% +2.21% +9.51% -11.45% +7.33% +13.86% -2.87% -1.30% +11.78% -8.58% +11.22% -1.99% +0.68% +4.87% +68.95% -39.08% -10.01% -4.69% +2.05% +10.21% -6.54% +1.17% -10.04% +22.75% -6.61% +1.71% +5.88% +13.64% -6.99% -0.75% -10.30% +16.54% -7.66% -1.82% -3.04% +9.64% -9.39% -3.38% -1.67% +12.75% -6.18% -3.01% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011
Americas (Excluding The United States) Revenue 120.93M 212.21M 194.38M 50.36M 64.27M 66.52M 91.17M 87.53M 361.45M 360.96M 375.47M 382.26M 364.59M
Americas (Excluding The United States) Revenue Growth -43.01% +9.17% +286.01% -21.65% -3.38% -27.04% +4.16% -75.78% +0.14% -3.87% -1.77% +4.85% n/a
Asia Pacific Revenue 197.40M 324.95M 342.44M 93.64M 101.33M 94.75M 138.33M 128.90M n/a n/a n/a n/a n/a
Asia Pacific Revenue Growth -39.25% -5.11% +265.71% -7.60% +6.95% -31.51% +7.32% n/a n/a n/a n/a n/a n/a
Emea Revenue 226.25M 395.87M 379.39M 91.00M 118.30M 113.00M 155.85M 147.99M n/a n/a n/a n/a n/a
Emea Revenue Growth -42.85% +4.34% +316.92% -23.08% +4.69% -27.50% +5.31% n/a n/a n/a n/a n/a n/a
United States Revenue 700.16M 1.16B 1.11B 139.72M 179.42M 172.46M 411.04M 399.11M n/a n/a n/a n/a n/a
United States Revenue Growth -39.53% +4.78% +690.94% -22.13% +4.03% -58.04% +2.99% n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 99.73M 121.84M 106.10M 127.33M 125.30M 129.70M 130.08M 120.74M 114.60M 115.83M 102.88M 107.28M 104.74M 104.40M 98.34M 99.10M 94.38M 84.47M 95.87M 102.00M 98.19M 100.73M 99.23M 96.46M 84.98M 89.60M 84.57M 92.41M 80.81M 83.83M 94.76M 86.72M 79.01M 86.73M 85.94M 82.67M 72.06M 73.58M 74.79M
Selling, General, and Administrative Revenue Growth -18.15% +14.84% -16.68% +1.62% -3.40% -0.29% +7.74% +5.36% -1.06% +12.59% -4.11% +2.43% +0.32% +6.16% -0.76% +5.00% +11.73% -11.88% -6.01% +3.89% -2.52% +1.51% +2.87% +13.51% -5.16% +5.95% -8.48% +14.35% -3.60% -11.54% +9.27% +9.76% -8.90% +0.91% +3.96% +14.73% -2.07% -1.61% n/a
Research and Development Revenue 13.56M 14.10M 13.59M 14.03M 12.46M 13.57M 12.54M 12.22M 12.77M 11.49M 10.67M 11.36M 10.86M 11.32M 10.03M 11.72M 9.94M 8.70M 10.12M 12.09M 10.98M 11.81M 10.57M 10.37M 14.12M 9.98M 7.71M 8.38M 8.27M 8.04M 7.62M 7.63M 8.35M 8.01M 8.26M 6.74M 6.65M 7.50M 6.54M
Research and Development Revenue Growth -3.83% +3.71% -3.09% +12.55% -8.16% +8.24% +2.61% -4.28% +11.09% +7.69% -6.06% +4.62% -4.06% +12.88% -14.42% +17.91% +14.21% -14.03% -16.32% +10.10% -6.95% +11.64% +1.97% -26.56% +41.43% +29.49% -7.96% +1.31% +2.85% +5.55% -0.21% -8.61% +4.30% -3.02% +22.50% +1.34% -11.32% +14.66% n/a